24-H PROFILE OF SERUM OSTEOCALCIN IN GROWTH-HORMONE (GH) DEFICIENT PATIENTS WITH AND WITHOUT GH TREATMENT

被引:0
作者
NIELSEN, HK
JORGENSEN, JOL
BRIXEN, K
MOLLER, N
CHARLES, P
CHRISTENSEN, JS
机构
[1] AARHUS KOMMUNE HOSP,DEPT MED ENDOCRINOL & METAB,AARHUS BONE & MINERAL RES GRP,DK-8000 AARHUS,DENMARK
[2] AARHUS KOMMUNE HOSP,DEPT MED M,DK-8000 AARHUS,DENMARK
来源
GROWTH REGULATION | 1991年 / 1卷 / 04期
关键词
CIRCADIAN RHYTHM; SERUM OSTEOCALCIN; GH-DEFICIENCY; GROWTH HORMONE TREATMENT; CHILDREN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum osteocalcin (OC), which is a specific, sensitive, and rapidly responding biochemical bone marker of osteoblastic activity, varies in a circadian rhythm in both normal adults and children with the highest levels during nighttime. In the present study, we characterized the 24-h rhythm of serum OC in 8 growth hormone (GH)-deficient children without treatment, and during two regimens of recombinant human GH (r-hGH), i.e. 2 IU/day s.c. at 08:00 h or at 20:00 h, in comparison with 5 normal, untreated children. Without treatment and when r-hGH was administered at 08:00 h, the 24-h profile of serum OC was correlated with that of the healthy controls in only 1 of 8 patients (r = 0.26 +/- 0.09 (mean +/- SE) and r = 0.10 +/- 0.08) whereas the correlation was significant in 6 of 8 patients (r = 0.44 +/- 0.05) during evening r-hGH administration. Within GH-deficient patients, mean OC level was lower during no r-hGH or evening administration compared with morning administration. In conclusion, untreated GH-deficient children have an abnormal 24-h serum OC profile. Evening administration of 2 IU of r-hGH/day s.c. tends to normalise the 24-h profile but not the average daily level, whereas morning administration of GH increases average daily OC level but does not normalize the circadian rhythm.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 39 条
[1]   TEMPORAL PATTERNS OF INTEGRATED PLASMA HORMONE LEVELS DURING SLEEP AND WAKEFULNESS .1. THYROID-STIMULATING HORMONE, GROWTH-HORMONE AND CORTISOL [J].
ALFORD, FP ;
BAKER, HWG ;
BURGER, HG ;
KRETSER, DMD ;
HUDSON, B ;
JOHNS, MW ;
MASTERTON, JP ;
PATEL, YC ;
RENNIE, GC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (06) :841-854
[2]  
BRIXEN K, 1990, J BONE MINER RES, V5, P609
[3]   EFFICACY OF WHEAT-GERM LECTIN-PRECIPITATED ALKALINE-PHOSPHATASE IN SERUM AS AN ESTIMATOR OF BONE MINERALIZATION RATE - COMPARISON TO SERUM TOTAL ALKALINE-PHOSPHATASE AND SERUM BONE GLA-PROTEIN [J].
BRIXEN, K ;
NIELSEN, HK ;
ERIKSEN, EF ;
CHARLES, P ;
MOSEKILDE, L .
CALCIFIED TISSUE INTERNATIONAL, 1989, 44 (02) :93-98
[4]   ESTIMATION OF BONE TURNOVER EVALUATED BY CA-47 KINETICS - EFFICIENCY OF SERUM BONE GAMMA-CARBOXYGLUTAMIC ACID-CONTAINING PROTEIN, SERUM ALKALINE-PHOSPHATASE, AND URINARY HYDROXYPROLINE EXCRETION [J].
CHARLES, P ;
POSER, JW ;
MOSEKILDE, L ;
JENSEN, FT .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2254-2258
[5]  
CHRISTENSEN SE, 1984, ACTA ENDOCRINOL-COP, V107, P137
[6]  
DELMAS PD, 1986, J BONE MINER RES, V1, P333
[7]   SERUM BONE GLA-PROTEIN COMPARED TO BONE HISTOMORPHOMETRY IN ENDOCRINE DISEASES [J].
DELMAS, PD ;
MALAVAL, L ;
ARLOT, ME ;
MEUNIER, PJ .
BONE, 1985, 6 (05) :339-341
[8]   EFFECT OF RENAL-FUNCTION ON PLASMA-LEVELS OF BONE GLA-PROTEIN [J].
DELMAS, PD ;
WILSON, DM ;
MANN, KG ;
RIGGS, BL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (05) :1028-1030
[9]  
DELMAS PD, 1986, 9TH INT C CALC REG H, pA447
[10]  
EASTELL R, 1988, J BONE MINER RES S1, V3, P539